Compounds > omega-n-methylarginine
Page last updated: 2024-09-03

omega-n-methylarginine and 3-o-methylglucose

omega-n-methylarginine has been researched along with 3-o-methylglucose in 3 studies

Compound Research Comparison

Studies
(omega-n-methylarginine)		Trials
(omega-n-methylarginine)		Recent Studies (post-2010)
(omega-n-methylarginine)		Studies
(3-o-methylglucose)		Trials
(3-o-methylglucose)		Recent Studies (post-2010) (3-o-methylglucose)
4,4113443361,2772564

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Etgen, GJ; Fryburg, DA; Gibbs, EM1
Canny, BJ; McConell, GK; Snow, RJ; Stephens, TJ1
Iida, M; Iwase, M; Nakamura, U; Nohara, S; Sasaki, N; Sonoki, K; Uchizono, Y1

Other Studies

3 other study(ies) available for omega-n-methylarginine and 3-o-methylglucose

ArticleYear
Nitric oxide stimulates skeletal muscle glucose transport through a calcium/contraction- and phosphatidylinositol-3-kinase-independent pathway.
    Diabetes, 1997, Volume: 46, Issue:11

    Topics: 3-O-Methylglucose; Androstadienes; Animals; Calcium; Dantrolene; Dibutyryl Cyclic GMP; Enzyme Inhibitors; Female; Glucose; Indazoles; Muscle Contraction; Muscle, Skeletal; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Phosphatidylinositol 3-Kinases; Rats; Rats, Sprague-Dawley; Sulfonamides; Wortmannin

1997
5'-aminoimidazole-4-carboxyamide-ribonucleoside-activated glucose transport is not prevented by nitric oxide synthase inhibition in rat isolated skeletal muscle.
    Clinical and experimental pharmacology & physiology, 2004, Volume: 31, Issue:7

    Topics: 3-O-Methylglucose; Aminoimidazole Carboxamide; Animals; Biological Transport, Active; Enzyme Inhibitors; Glucose; In Vitro Techniques; Male; Muscle Contraction; Muscle, Skeletal; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Ribonucleotides

2004
Nateglinide, a non-sulfonylurea rapid insulin secretagogue, increases pancreatic islet blood flow in rats.
    European journal of pharmacology, 2005, Aug-22, Volume: 518, Issue:2-3

    Topics: 3-O-Methylglucose; Administration, Oral; Anesthesia; Animals; Blood Glucose; Blood Pressure; Consciousness; Cyclohexanes; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Gastrointestinal Tract; Glucose; Hypoglycemic Agents; Injections, Intravenous; Insulin; Insulin Secretion; Islets of Langerhans; Male; Nateglinide; Nitric Oxide Synthase; omega-N-Methylarginine; Phenylalanine; Rats; Rats, Inbred OLETF; Rats, Sprague-Dawley; Regional Blood Flow; Time Factors; Tolbutamide

2005